Publications by authors named "Beverly Metchock"

Claim this Profile
B
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates.
Koné Kaniga, Rumina Hasan, Ruwen Jou, Edita Vasiliauskienė, Charoen Chuchottaworn, Beverly Metchock

J Clin Microbiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Unified Data Exchange Formats for Reporting Molecular Drug Susceptibility Testing.
Wilfred Bonney, Sandy F Price, , Swapna Abhyankar, Riki Merrick, Beverly Metchock

Online J Public Health Inform· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, Stefan V Goldberg, Lorna Bozeman, Beverly Metchock

Contemp Clin Trials· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Beverly Metchock

Antimicrob Agents Chemother· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Public Health Laboratory Response After Hurricane Maria - Puerto Rico, 2017.
Jeniffer Concepción-Acevedo, Anita Patel, Carolina Luna-Pinto, Rafael González Peña, Rosa Ivette Cuevas Ruiz, Beverly Metchock

MMWR Morb Mortal Wkly Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Health Department in Tuberculosis Prevention and Control-Legal and Public Health Considerations.
Carla Jeffries, Phil Lobue, Terence Chorba, Beverly Metchock, Ijaz Kashef

Microbiol Spectr· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
Koné Kaniga, Daniela M Cirillo, Sven Hoffner, Nazir A Ismail, Devinder Kaur, Beverly Metchock

J Clin Microbiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
Koné Kaniga, Daniela M Cirillo, Sven Hoffner, Nazir A Ismail, Devinder Kaur, Beverly Metchock

J Clin Microbiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison McAlister, David Sikes, Denise Hartline, Beverly Metchock

Tuberc Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
Anne F Luetkemeyer, Cynthia Firnhaber, Michelle A Kendall, Xingye Wu, Gerald H Mazurek, Beverly Metchock

Clin Infect Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
J Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, Jeannette Brand, Julia Ershova, Beverly Metchock

Clin Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
Melisa Willby, R David Sikes, Seidu Malik, Beverly Metchock, James E Posey

Antimicrob Agents Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay.
Allison J McAlister, Jeffrey Driscoll, Beverly Metchock

J Clin Microbiol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.
Mitchell A Yakrus, Beverly Metchock, Angela M Starks

Tuberc Res Treat· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison J Lentz, David Sikes, Denise Hartline, Beverly Metchock

J Clin Microbiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing.
Ameeta S Kalokhe, Majid Shafiq, James C Lee, Susan M Ray, Yun F Wang, Beverly Metchock

Am J Med Sci· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Tracy Dalton, Peter Cegielski, Somsak Akksilp, Luis Asencios, Janice Campos Caoili, Beverly Metchock

Lancet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.
Pawan K Angra, Thomas H Taylor, Michael F Iademarco, Beverly Metchock, J Rex Astles

J Clin Microbiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance in Mycobacterium tuberculosis rifampin susceptibility.
Ameeta S Kalokhe, Majid Shafiq, James C Lee, Beverly Metchock, James E Posey

Emerg Infect Dis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.
William R Mac Kenzie, Charles M Heilig, Lorna Bozeman, John L Johnson, Grace Muzanye, Beverly Metchock

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
M Analise Zaunbrecher, R David Sikes, Beverly Metchock, Thomas M Shinnick, James E Posey

Proc Natl Acad Sci U S A· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission network analysis to complement routine tuberculosis contact investigations.
McKenzie Andre, Kashef Ijaz, Jon D Tillinghast, Valdis E Krebs, Lois A Diem, Beverly Metchock

Am J Public Health· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide emergence of extensively drug-resistant tuberculosis.
N Sarita Shah, Abigail Wright, Gill-Han Bai, Lucia Barrera, Fadila Boulahbal, Beverly Metchock

Emerg Infect Dis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.
Gerald H Mazurek, John Jereb, Phillip Lobue, Michael F Iademarco, Beverly Metchock

MMWR Recomm Rep· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis